Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Expanded Recommendations for OBRONA

24 Jul 2024 07:00

RNS Number : 5304X
Plant Health Care PLC
24 July 2024
 

24 July 2024

 

Plant Health Care plc

 ("Plant Health Care" or the "Company")

 

Expanded Recommendations to Support Commercial Sales of OBRONA® Biochemical Fungicide for Use on Corn, Soybean, and Wheat

  

Plant Health Care® (AIM.PHC.L), a leading provider of peptides used by growers to improve crop production and quality within global agriculture markets, is pleased to announce the issuance of new recommendations for use of OBRONA® biochemical fungicide to provide farmers with another tool to control a wide range of diseases and improve crop yield and harvest quality in corn, soybean and wheat in key US states.

 

Highlights:

- The new Section 2(ee) recommendations cover the use of OBRONA to control diseases in the following crops:

· Control in corn of common rust, gray leaf spot, northern and southern corn leaf blight and tar spot,

· Control in soybean of downy mildew, frogeye leaf spot, sclerotinia stem rot, and white mold,

· Control in wheat of multiple rust species: black, leaf, stem, stripe, and yellow rust. 

- These diseases represent serious threats to agricultural production and can significantly reduce crop yields, harvest quality, and grower profitability if not properly managed. OBRONA provides growers with a novel mode of action and an environmentally friendly tool to control these diseases and support sustainable agriculture based on reduced reliance on established synthetic pesticides. 

 

Section 2(ee) of the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA) allows users to apply pesticides under certain limited conditions that are not specified on the commercial label. The recommendations shown above have been written to address control of target pests not listed on the OBRONA label.

 

Compared to current biocontrol products, OBRONA provides highly consistent and convenient product performance to control a broad spectrum of fungal and bacterial plant diseases. In addition to providing growers with a favorable return on investment, OBRONA brings growers convenience as it is compatible with many commonly used fungicides, herbicides, and insecticides in tank-mix and sequential application programs. OBRONA has no special requirements for storing or handling, which allows greater flexibility within the distribution channel and ease of on-farm application.

  

Jeff Tweedy, CEO of Plant Health Care, said: ‟Wilbur-Ellis is aggressively launching OBRONA this summer across the mid-west for disease control in corn, soybean and wheat. Results from field testing of OBRONA are very promising and we are excited to continue working with Wilbur-Ellis to bring the benefits of OBRONA to a wide range of growers across the country for the 2024 season."

 

  

# # #

 

For further information, please contact: 

Plant Health Care plc Jeff Tweedy, CEO

 

Tel: +1 919 926 1600

 

 

Cavendish Capital Markets Limited - Nomad & Broker Neil McDonald / Pete Lynch

 

Tel: +44 (0) 131 220 9771

 

 

For further information about Wilbur-Ellis, please contact: Jeanne Forbis, jforbis@wilburellis.com

 

 

About Plant Health Care

Plant Health Care offers products to improve the health, vigour and yield of major field crops such as corn, soybeans, sugarcane, potatoes, rice, and wheat, as well as specialty crops such as fruits and vegetables. We operate globally through subsidiaries, distributors, and supply agreements with major industry partners. Our innovative, patent-protected biological products help growers to protect their crops from stress and diseases, and to produce higher quality fruit and vegetables, with a favourable environmental profile.

 

Find out more at www.planthealthcare.com

 

About the Wilbur-Ellis Companies 

Founded in 1921, the Wilbur-Ellis companies are leading marketers, distributors and manufacturers of agricultural products and animal nutrients. By developing strong relationships, making strategic market investments, and capitalizing on new opportunities, the Wilbur-Ellis companies have continued to grow the business with sales of over $3.5 billion. For more information, please visit www.wilburellis.com

Wilbur-Ellis Agriculture, with annual sales revenue of $2.5 billion, has over 150 retail locations throughout the U.S.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
REAQKNBKABKDQOB
Date   Source Headline
12th Nov 20193:56 pmRNSHolding(s) in Company
6th Nov 201912:57 pmRNSInvestment in Company by Ospraie Ag Science LLC
30th Oct 20197:00 amRNSAppointment of new Board Directors
3rd Oct 20192:50 pmRNSDirector/PDMR Shareholding
30th Sep 20197:00 amRNSInterim Report ended 30 June 2019
9th Sep 20197:00 amRNSPilot production of PREtec peptides
19th Aug 20197:00 amRNSBlock listing Interim Review
15th Aug 20197:00 amRNSProgress with PREtec field trials in Brazil
5th Aug 20195:18 pmRNSHolding(s) in Company
25th Jun 20197:00 amRNSNew Distribution Agreement with Wilbur-Ellis
12th Jun 201911:05 amRNSResult of AGM
30th Apr 20194:19 pmRNSAnnual Report & Accounts and AGM Notice Published
10th Apr 20197:00 amRNSResults for the year ended 31 December 2018
27th Mar 20193:41 pmRNSHolding(s) in Company
28th Feb 20197:00 amRNSNew Technology Update
19th Feb 20197:00 amRNSBlock listing Interim Review
29th Jan 20197:00 amRNSTrading Statement
24th Jan 20195:58 pmRNSHolding(s) in Company
21st Dec 20187:00 amRNSTrading Statement
28th Nov 20187:00 amRNSNew Technology Update
21st Nov 20187:00 amRNSPlant Health Care ProAct® Wins Top Industry Award
19th Nov 20187:00 amRNSPlant Health Care to present at Mello London
14th Nov 20187:00 amRNSPositive Developments with Harpin
8th Nov 20187:00 amRNSChange of Adviser
5th Nov 20187:00 amRNSHolding(s) in Company
18th Sep 20187:00 amRNSInterim Report ended 30 June 2018
12th Sep 20187:00 amRNSUS Announces Harpin aß Product Launch in Corn
20th Aug 20187:00 amRNSBlock listing Interim Review
30th Jul 20187:00 amRNSUpdate on sugarcane in Brazil
16th Jul 20187:00 amRNSTrading Statement
6th Jun 20182:39 pmRNSHolding(s) in Company
6th Jun 201811:14 amRNSResult of AGM
30th May 20187:00 amRNSGrant of Options
4th May 20185:59 pmRNSHolding(s) in Company
30th Apr 20183:11 pmRNSPublication of Annual Report and Notice of AGM
10th Apr 20187:00 amRNSResults for the year ended 31 December 2017
8th Mar 20187:00 amRNSBlock listing Interim Review
7th Mar 20183:07 pmRNSHolding(s) in Company
7th Mar 20183:06 pmRNSHolding(s) in Company
7th Mar 20183:02 pmRNSHolding(s) in Company
2nd Mar 20185:48 pmRNSHolding(s) in Company
27th Feb 20184:12 pmRNSResult of Placing and Subscription
27th Feb 20187:00 amRNSProposed Placing and Subscription
24th Jan 20187:00 amRNSTrading Statement
12th Dec 20177:00 amRNSNew Technology Update
8th Dec 20174:35 pmRNSPrice Monitoring Extension
6th Dec 20174:40 pmRNSSecond Price Monitoring Extn
6th Dec 20174:35 pmRNSPrice Monitoring Extension
18th Sep 20177:00 amRNSHalf-year Report
21st Aug 20177:00 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.